 | • レポートコード：MRC2102QY6376 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の帯状疱疹治療薬市場について種類別（アシクロビル、アメナメビル、FV-100、GLS-5100、GSK-1437173A、NAL-3221、その他）、用途別（クリニック、病院、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・帯状疱疹治療薬市場の概要 ・世界の主要地域別帯状疱疹治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の帯状疱疹治療薬市場規模2015-2026：種類別（アシクロビル、アメナメビル、FV-100、GLS-5100、GSK-1437173A、NAL-3221、その他） ・世界の帯状疱疹治療薬市場規模2015-2026：用途別（クリニック、病院、その他） ・帯状疱疹治療薬の米国市場規模2015-2020 ・帯状疱疹治療薬のヨーロッパ市場規模2015-2020 ・帯状疱疹治療薬の中国市場規模2015-2020 ・帯状疱疹治療薬の日本市場規模2015-2020 ・帯状疱疹治療薬の東南アジア市場規模2015-2020 ・帯状疱疹治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・帯状疱疹治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・帯状疱疹治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Herpes Zoste Drug Market
The global Herpes Zoste Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Herpes Zoste Drug Scope and Market Size
The global Herpes Zoste Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Zoste Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Herpes Zoste Drug market is segmented into
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others
Segment by Application, the Herpes Zoste Drug market is segmented into
Clinic
Hospital
Others
The Herpes Zoste Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Herpes Zoste Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Herpes Zoste Drug Market Share Analysis
Herpes Zoste Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Zoste Drug business, the date to enter into the Herpes Zoste Drug market, Herpes Zoste Drug product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.
1 Herpes Zoste Drug Market Overview
1.1 Herpes Zoste Drug Product Scope
1.2 Herpes Zoste Drug Segment by Type
1.2.1 Global Herpes Zoste Drug Sales by Type (2020-2026)
1.2.2 Acyclovir
1.2.3 Amenamevir
1.2.4 FV-100
1.2.5 GLS-5100
1.2.6 GSK-1437173A
1.2.7 NAL-3221
1.2.8 Others
1.3 Herpes Zoste Drug Segment by Application
1.3.1 Global Herpes Zoste Drug Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Herpes Zoste Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Herpes Zoste Drug Sales Growth Rate (2015-2026)
1.4.2 Global Herpes Zoste Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Herpes Zoste Drug Price Trends (2015-2026)
2 Herpes Zoste Drug Estimate and Forecast by Region
2.1 Global Herpes Zoste Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Herpes Zoste Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Herpes Zoste Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Herpes Zoste Drug Revenue Market Share by Region (2015-2020)
2.3 Global Herpes Zoste Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Herpes Zoste Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Herpes Zoste Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Herpes Zoste Drug Estimates and Projections (2015-2026)
2.4.2 Europe Herpes Zoste Drug Estimates and Projections (2015-2026)
2.4.3 China Herpes Zoste Drug Estimates and Projections (2015-2026)
2.4.4 Japan Herpes Zoste Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Herpes Zoste Drug Estimates and Projections (2015-2026)
2.4.6 India Herpes Zoste Drug Estimates and Projections (2015-2026)
3 Global Herpes Zoste Drug Competition Landscape by Players
3.1 Global Top Herpes Zoste Drug Players by Sales (2015-2020)
3.2 Global Top Herpes Zoste Drug Players by Revenue (2015-2020)
3.3 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoste Drug as of 2019)
3.4 Global Herpes Zoste Drug Average Price by Company (2015-2020)
3.5 Manufacturers Herpes Zoste Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Herpes Zoste Drug Players (Opinion Leaders)
4 Global Herpes Zoste Drug Market Size by Type
4.1 Global Herpes Zoste Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Herpes Zoste Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Herpes Zoste Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Herpes Zoste Drug Price by Type (2015-2020)
4.2 Global Herpes Zoste Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Herpes Zoste Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Zoste Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Herpes Zoste Drug Price Forecast by Type (2021-2026)
5 Global Herpes Zoste Drug Market Size by Application
5.1 Global Herpes Zoste Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Herpes Zoste Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Herpes Zoste Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Herpes Zoste Drug Price by Application (2015-2020)
5.2 Global Herpes Zoste Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Herpes Zoste Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Zoste Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Zoste Drug Price Forecast by Application (2021-2026)
6 United States Herpes Zoste Drug Market Facts & Figures
6.1 United States Herpes Zoste Drug Sales Market Share by Company (2015-2020)
6.2 United States Herpes Zoste Drug Sales Market Share by Type (2015-2020)
6.3 United States Herpes Zoste Drug Sales Market Share by Application (2015-2020)
7 Europe Herpes Zoste Drug Market Facts & Figures
7.1 Europe Herpes Zoste Drug Sales Market Share by Company (2015-2020)
7.2 Europe Herpes Zoste Drug Sales Market Share by Type (2015-2020)
7.3 Europe Herpes Zoste Drug Sales Market Share by Application (2015-2020)
8 China Herpes Zoste Drug Market Facts & Figures
8.1 China Herpes Zoste Drug Sales Market Share by Company (2015-2020)
8.2 China Herpes Zoste Drug Sales Market Share by Type (2015-2020)
8.3 China Herpes Zoste Drug Sales Market Share by Application (2015-2020)
9 Japan Herpes Zoste Drug Market Facts & Figures
9.1 Japan Herpes Zoste Drug Sales Market Share by Company (3015-3030)
9.2 Japan Herpes Zoste Drug Sales Market Share by Type (2015-2020)
9.3 Japan Herpes Zoste Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Herpes Zoste Drug Market Facts & Figures
10.1 Southeast Asia Herpes Zoste Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Herpes Zoste Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Herpes Zoste Drug Sales Market Share by Application (2015-2020)
11 India Herpes Zoste Drug Market Facts & Figures
11.1 India Herpes Zoste Drug Sales Market Share by Company (2015-2020)
11.2 India Herpes Zoste Drug Sales Market Share by Type (2015-2020)
11.3 India Herpes Zoste Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Herpes Zoste Drug Business
12.1 Astellas Pharma Inc.
12.1.1 Astellas Pharma Inc. Corporation Information
12.1.2 Astellas Pharma Inc. Business Overview
12.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
12.1.5 Astellas Pharma Inc. Recent Development
12.2 Beijing Minhai Biotechnology Co., Ltd
12.2.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
12.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
12.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Products Offered
12.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Development
12.3 ContraVir Pharmaceuticals, Inc.
12.3.1 ContraVir Pharmaceuticals, Inc. Corporation Information
12.3.2 ContraVir Pharmaceuticals, Inc. Business Overview
12.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Products Offered
12.3.5 ContraVir Pharmaceuticals, Inc. Recent Development
12.4 Epiphany Biosciences, Inc.
12.4.1 Epiphany Biosciences, Inc. Corporation Information
12.4.2 Epiphany Biosciences, Inc. Business Overview
12.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Products Offered
12.4.5 Epiphany Biosciences, Inc. Recent Development
12.5 Foamix Pharmaceuticals Ltd.
12.5.1 Foamix Pharmaceuticals Ltd. Corporation Information
12.5.2 Foamix Pharmaceuticals Ltd. Business Overview
12.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
12.5.5 Foamix Pharmaceuticals Ltd. Recent Development
12.6 GeneOne Life Science, Inc.
12.6.1 GeneOne Life Science, Inc. Corporation Information
12.6.2 GeneOne Life Science, Inc. Business Overview
12.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Products Offered
12.6.5 GeneOne Life Science, Inc. Recent Development
12.7 GlaxoSmithKline Plc
12.7.1 GlaxoSmithKline Plc Corporation Information
12.7.2 GlaxoSmithKline Plc Business Overview
12.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Products Offered
12.7.5 GlaxoSmithKline Plc Recent Development
12.8 Merck & Co., Inc.
12.8.1 Merck & Co., Inc. Corporation Information
12.8.2 Merck & Co., Inc. Business Overview
12.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck & Co., Inc. Herpes Zoste Drug Products Offered
12.8.5 Merck & Co., Inc. Recent Development
12.9 NAL Pharmaceuticals Ltd.
12.9.1 NAL Pharmaceuticals Ltd. Corporation Information
12.9.2 NAL Pharmaceuticals Ltd. Business Overview
12.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
12.9.5 NAL Pharmaceuticals Ltd. Recent Development
12.10 ReceptoPharm, Inc.
12.10.1 ReceptoPharm, Inc. Corporation Information
12.10.2 ReceptoPharm, Inc. Business Overview
12.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Products Offered
12.10.5 ReceptoPharm, Inc. Recent Development
12.11 TSRL, Inc.
12.11.1 TSRL, Inc. Corporation Information
12.11.2 TSRL, Inc. Business Overview
12.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 TSRL, Inc. Herpes Zoste Drug Products Offered
12.11.5 TSRL, Inc. Recent Development
13 Herpes Zoste Drug Manufacturing Cost Analysis
13.1 Herpes Zoste Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Herpes Zoste Drug
13.4 Herpes Zoste Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Herpes Zoste Drug Distributors List
14.3 Herpes Zoste Drug Customers
15 Market Dynamics
15.1 Herpes Zoste Drug Market Trends
15.2 Herpes Zoste Drug Opportunities and Drivers
15.3 Herpes Zoste Drug Market Challenges
15.4 Herpes Zoste Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Herpes Zoste Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Herpes Zoste Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Herpes Zoste Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Herpes Zoste Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Herpes Zoste Drug Sales Market Share by Region (2015-2020)
Table 6. Global Herpes Zoste Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Herpes Zoste Drug Revenue Share by Region (2015-2020)
Table 8. Global Herpes Zoste Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Herpes Zoste Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Herpes Zoste Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Herpes Zoste Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Herpes Zoste Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Herpes Zoste Drug Sales Share by Company (2015-2020)
Table 14. Global Herpes Zoste Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Herpes Zoste Drug Revenue Share by Company (2015-2020)
Table 16. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoste Drug as of 2019)
Table 17. Global Herpes Zoste Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Herpes Zoste Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Herpes Zoste Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Herpes Zoste Drug Players
Table 22. Global Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Herpes Zoste Drug Sales Share by Type (2015-2020)
Table 24. Global Herpes Zoste Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Herpes Zoste Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Herpes Zoste Drug Sales Share by Type (2021-2026)
Table 27. Global Herpes Zoste Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Herpes Zoste Drug Revenue Share by Type (2021-2026)
Table 29. Global Herpes Zoste Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Herpes Zoste Drug Sales Share by Application (2015-2020)
Table 32. Global Herpes Zoste Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Herpes Zoste Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Herpes Zoste Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Herpes Zoste Drug Sales Share by Application (2021-2026)
Table 36. Global Herpes Zoste Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Herpes Zoste Drug Revenue Share by Application (2021-2026)
Table 38. Global Herpes Zoste Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 41. United States Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 43. United States Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 51. China Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 53. China Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 55. China Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Table 69. India Herpes Zoste Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Herpes Zoste Drug Sales Market Share by Company (2015-2020)
Table 71. India Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Table 73. India Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Table 75. Astellas Pharma Inc. Corporation Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Astellas Pharma Inc. Herpes Zoste Drug Product
Table 79. Astellas Pharma Inc. Recent Development
Table 80. Beijing Minhai Biotechnology Co., Ltd Corporation Information
Table 81. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
Table 82. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product
Table 84. Beijing Minhai Biotechnology Co., Ltd Recent Development
Table 85. ContraVir Pharmaceuticals, Inc. Corporation Information
Table 86. ContraVir Pharmaceuticals, Inc. Description and Business Overview
Table 87. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product
Table 89. ContraVir Pharmaceuticals, Inc. Recent Development
Table 90. Epiphany Biosciences, Inc. Corporation Information
Table 91. Epiphany Biosciences, Inc. Description and Business Overview
Table 92. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Epiphany Biosciences, Inc. Herpes Zoste Drug Product
Table 94. Epiphany Biosciences, Inc. Recent Development
Table 95. Foamix Pharmaceuticals Ltd. Corporation Information
Table 96. Foamix Pharmaceuticals Ltd. Description and Business Overview
Table 97. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product
Table 99. Foamix Pharmaceuticals Ltd. Recent Development
Table 100. GeneOne Life Science, Inc. Corporation Information
Table 101. GeneOne Life Science, Inc. Description and Business Overview
Table 102. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. GeneOne Life Science, Inc. Herpes Zoste Drug Product
Table 104. GeneOne Life Science, Inc. Recent Development
Table 105. GlaxoSmithKline Plc Corporation Information
Table 106. GlaxoSmithKline Plc Description and Business Overview
Table 107. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. GlaxoSmithKline Plc Herpes Zoste Drug Product
Table 109. GlaxoSmithKline Plc Recent Development
Table 110. Merck & Co., Inc. Corporation Information
Table 111. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Merck & Co., Inc. Description and Business Overview
Table 113. Merck & Co., Inc. Herpes Zoste Drug Product
Table 114. Merck & Co., Inc. Recent Development
Table 115. NAL Pharmaceuticals Ltd. Corporation Information
Table 116. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. NAL Pharmaceuticals Ltd. Description and Business Overview
Table 118. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product
Table 119. NAL Pharmaceuticals Ltd. Recent Development
Table 120. ReceptoPharm, Inc. Corporation Information
Table 121. ReceptoPharm, Inc. Description and Business Overview
Table 122. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. ReceptoPharm, Inc. Herpes Zoste Drug Product
Table 124. ReceptoPharm, Inc. Recent Development
Table 125. TSRL, Inc. Corporation Information
Table 126. TSRL, Inc. Description and Business Overview
Table 127. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. TSRL, Inc. Herpes Zoste Drug Product
Table 129. TSRL, Inc. Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Herpes Zoste Drug Distributors List
Table 133. Herpes Zoste Drug Customers List
Table 134. Herpes Zoste Drug Market Key Trends
Table 135. Herpes Zoste Drug Key Opportunities and Drivers
Table 136. Herpes Zoste Drug Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Zoste Drug Product Picture
Figure 2. Global Herpes Zoste Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Herpes Zoste Drug Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Herpes Zoste Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Herpes Zoste Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Herpes Zoste Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Herpes Zoste Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Herpes Zoste Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Herpes Zoste Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Herpes Zoste Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Herpes Zoste Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Herpes Zoste Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Herpes Zoste Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Herpes Zoste Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Herpes Zoste Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Herpes Zoste Drug Players Market Share by Revenue in Herpes Zoste Drug 2015 & 2019
Figure 27. Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Herpes Zoste Drug Revenue Share by Type (2015-2020)
Figure 29. Global Herpes Zoste Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Herpes Zoste Drug Revenue Share by Application (2015-2020)
Figure 31. Global Herpes Zoste Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 33. United States Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 34. Europe Herpes Zoste Drug Sales Market Share by Company in 2019
Figure 35. Europe Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 36. Europe Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 37. China Herpes Zoste Drug Sales Market Share by Company in 2019
Figure 38. China Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 39. China Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 40. Japan Herpes Zoste Drug Sales Market Share by Company in 2019
Figure 41. Japan Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 42. Japan Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Herpes Zoste Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 46. India Herpes Zoste Drug Sales Market Share by Company in 2019
Figure 47. India Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 48. India Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Herpes Zoste Drug
Figure 51. Manufacturing Process Analysis of Herpes Zoste Drug
Figure 52. Herpes Zoste Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …
- 耳鳴症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Tinnitus Drug Market The global Tinnitus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tinnitus Drug Scope and Market Size The global Tinnitus Drug market is segmented by comp…
- 甲状腺ホルモン薬の世界市場レポート2020 Market Analysis and Insights: Global Thyroid Hormone Disorder Drug Market The global Thyroid Hormone Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Thyroid Hormone Disorder Drug Scope and Market Size The …